RF Acquisition Corp III announced a business combination agreement with HCC Healthcare to pursue a Nasdaq listing, marking a significant step in its transition from a SPAC to an operating company.

• On July 9, 2026, RF Acquisition Corp III entered into a Business Combination Agreement with HCC Healthcare Pte. Ltd. and its subsidiary to pursue a Nasdaq listing through a business combination, approved by the respective boards of directors [N1].
• The company completed its IPO on February 17, 2026, raising $100 million through the issuance of 10 million units, each consisting of one ordinary share and one right to receive one-tenth of an ordinary share upon business combination completion [S1].
• As of June 30, 2026, the company reported cash and cash equivalents of $891,600 and a current ratio of 2.7, indicating a strong liquidity position [S1].

The company has secured a business combination agreement with HCC Healthcare, which could provide a pathway to becoming a publicly listed operating company on Nasdaq. The approval of the boards and the execution of definitive agreements demonstrate progress in the company’s strategic objectives. The company’s liquidity position as of June 30, 2026, shows sufficient cash and current assets relative to liabilities, supporting operational stability during the transition.

The company’s business model is contingent on completing the business combination, which carries risks including regulatory approvals, shareholder approvals, and market conditions. The company currently lacks operating revenues and detailed segment disclosures, limiting visibility into future performance. Risks disclosed in the IPO prospectus remain relevant and could materially affect outcomes. The company’s net income and EPS figures are minimal and reflect early-stage financials typical of a SPAC prior to business combination.

As a SPAC, RF Acquisition Corp III’s moat is primarily dependent on its ability to successfully identify and complete a value-accretive business combination. The company’s moat is limited until the business combination is consummated and the operating company establishes competitive advantages in its industry.

• Business Combination Risks: Completion of the business combination is subject to regulatory and shareholder approvals, which may be delayed, conditioned, or not obtained, potentially impacting the company’s transition to an operating entity.
• Operational Uncertainty: As a SPAC, the company currently lacks operating revenues and detailed operational disclosures, creating uncertainty about future business performance post-combination.
• Market and Regulatory Risks: Changes in market conditions, regulatory environments, and economic factors could adversely affect the combined company’s prospects and valuation.

• RF Acquisition Corp III is a Cayman Islands exempted company with limited liability operating as a special purpose acquisition company (SPAC).
• The company completed its initial public offering (IPO) on February 17, 2026, issuing 10,000,000 units at $10.00 per unit, raising gross proceeds of $100 million.
• Each unit consists of one ordinary share and one right to receive one-tenth of one ordinary share upon completion of the initial business combination.
• The company also completed a private placement of 350,000 units concurrently with the IPO.
• The proceeds from the IPO were deposited into a trust account.
• The company is listed on The Nasdaq Stock Market LLC under the ticker symbols RFAM (ordinary shares), RFAMU (units), and RFAMR (rights).
• RF Acquisition Corp III is classified as an emerging growth company under SEC rules.
• On July 9, 2026, RF Acquisition Corp III entered into a Business Combination Agreement with HCC Healthcare Pte. Ltd. and its subsidiary, HCC Merger Sub Limited, to pursue a Nasdaq listing through a business combination.
• The Business Combination Agreement was approved by the boards of directors of RF Acquisition Corp III, HCC Healthcare, and Merger Sub.
• The company reported cash and cash equivalents of $891,600 and current assets of $945,548 as of June 30, 2026, with current liabilities of $349,808, resulting in a current ratio of 2.7 and a cash ratio of 2.55.
• The company reported net income of $566,737 for the quarter ending June 30, 2026.
• Basic and diluted earnings per share were reported as -$0.01 for the period ending December 31, 2025.
• Risk factors disclosed in the company's final prospectus for the IPO remain unchanged as of the latest quarterly report.
• The company’s business model centers on completing a business combination to transition from a SPAC to an operating company.
• The company’s sponsor is Alfa 30 Limited, which participated in the private placement.
• The company has entered into various agreements related to the IPO and business combination, including underwriting, rights, registration rights, and trust agreements.
• The company’s financial figures are summarized from the latest available SEC filings and are provided for informational purposes only, not financial advice.
• HCC Healthcare signed a business combination agreement with RF Acquisition Corp III to pursue a Nasdaq listing, as announced on July 9, 2026.